Sanuwave Health Return on Tangible Equity 2012-2025 | SNWV
Current and historical return on tangible equity values for Sanuwave Health (SNWV) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Sanuwave Health Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-09-30 | $-0.01B | $-0.01B | 35.56% |
| 2025-06-30 | $-0.04B | $-0.03B | 105.41% |
| 2025-03-31 | $-0.03B | $-0.03B | 75.86% |
| 2024-12-31 | $-0.03B | $-0.02B | 62.44% |
| 2024-09-30 | $0.00B | $-0.07B | 1.69% |
| 2024-06-30 | $0.00B | $-0.05B | 6.58% |
| 2024-03-31 | $-0.02B | $-0.06B | 27.17% |
| 2023-12-31 | $-0.03B | $-0.06B | 38.24% |
| 2023-09-30 | $-0.05B | $-0.08B | 74.07% |
| 2023-06-30 | $-0.03B | $-0.07B | 45.57% |
| 2023-03-31 | $-0.02B | $-0.07B | 34.12% |
| 2022-12-31 | $-0.01B | $-0.05B | 20.51% |
| 2022-09-30 | $-0.01B | $-0.05B | 26.80% |
| 2022-06-30 | $-0.02B | $-0.05B | 33.33% |
| 2022-03-31 | $-0.03B | $-0.05B | 58.70% |
| 2021-12-31 | $-0.03B | $-0.05B | 65.85% |
| 2021-09-30 | $-0.03B | $-0.04B | 85.71% |
| 2021-06-30 | $-0.04B | $-0.04B | 121.88% |
| 2021-03-31 | $-0.03B | $-0.03B | 130.77% |
| 2020-12-31 | $-0.03B | $-0.03B | 147.13% |
| 2020-09-30 | $-0.02B | $-0.03B | 133.33% |
| 2020-06-30 | $-0.01B | $-0.02B | 101.96% |
| 2020-03-31 | $-0.01B | $-0.01B | 92.31% |
| 2019-12-31 | $-0.01B | $-0.01B | 80.00% |
| 2019-09-30 | $-0.01B | $-0.01B | 66.67% |
| 2019-06-30 | $-0.01B | $-0.02B | 53.33% |
| 2019-03-31 | $-0.01B | $-0.02B | 54.24% |
| 2018-12-31 | $-0.01B | $-0.02B | 84.21% |
| 2018-09-30 | $-0.01B | $-0.01B | 100.00% |
| 2018-06-30 | $-0.01B | $-0.02B | 108.33% |
| 2018-03-31 | $-0.01B | $-0.01B | 107.32% |
| 2017-12-31 | $-0.01B | $-0.01B | 58.82% |
| 2017-09-30 | $0.00B | $-0.01B | 51.61% |
| 2017-06-30 | $0.00B | $-0.01B | 57.14% |
| 2017-03-31 | $0.00B | $-0.01B | 61.54% |
| 2016-12-31 | $-0.01B | $-0.01B | 96.00% |
| 2016-09-30 | $-0.01B | $-0.01B | 83.33% |
| 2016-06-30 | $-0.01B | $-0.01B | 83.33% |
| 2016-03-31 | $-0.01B | $-0.01B | 104.35% |
| 2015-12-31 | $-0.01B | $-0.01B | 100.00% |
| 2015-09-30 | $0.00B | $-0.01B | 100.00% |
| 2015-06-30 | $0.00B | $-0.01B | 145.45% |
| 2015-03-31 | $0.00B | $0.00B | 266.67% |
| 2014-12-31 | $-0.01B | $0.00B | 1200.00% |
| 2014-09-30 | $-0.01B | $0.00B | 400.00% |
| 2014-06-30 | $-0.01B | $0.00B | 307.69% |
| 2014-03-31 | $-0.01B | $0.00B | 138.46% |
| 2013-12-31 | $-0.01B | $-0.01B | 112.82% |
| 2013-09-30 | $-0.01B | $-0.01B | 120.00% |
| 2013-06-30 | $-0.01B | $-0.01B | 90.00% |
| 2013-03-31 | $-0.01B | $-0.01B | 109.09% |
| 2012-12-31 | $-0.01B | $-0.01B | 92.31% |
| 2012-09-30 | $-0.01B | $-0.01B | 114.29% |
| 2012-06-30 | $-0.01B | $-0.01B | 186.67% |
| 2012-03-31 | $-0.01B | $-0.01B | 444.44% |
| 2011-12-31 | $-0.01B | $0.00B | 285.71% |
| 2011-09-30 | $-0.02B | $0.00B | 260.87% |
| 2011-06-30 | $-0.02B | $0.00B | 172.97% |
| 2011-03-31 | $-0.02B | $-0.01B | 120.00% |
| 2010-12-31 | $-0.02B | $-0.01B | 128.00% |
| 2010-09-30 | $-0.01B | $-0.02B | 104.35% |
| 2010-06-30 | $-0.01B | $-0.01B | 129.73% |
| 2010-03-31 | $-0.01B | $-0.01B | 133.33% |
| 2009-12-31 | $-0.01B | $-0.01B | 200.00% |
| 2009-09-30 | $-0.01B | $-0.01B | 400.00% |
| 2009-06-30 | $-0.01B | $0.00B | 800.00% |
| 2009-03-31 | $-0.01B | $0.00B | 880.00% |
| 2008-12-31 | $-0.01B | $-0.01B | 720.00% |
| 2008-09-30 | $0.00B | $0.00B | 0.00% |
| 2008-06-30 | $0.00B | $0.00B | 0.00% |
| 2008-03-31 | $0.00B | $0.00B | 0.00% |
| 2007-12-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.235B | $0.033B |
| SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $188.859B | 21.09 |
| EssilorLuxottica (ESLOY) | France | $145.490B | 0.00 |
| Stryker (SYK) | United States | $137.164B | 27.23 |
| Boston Scientific (BSX) | United States | $135.332B | 30.95 |
| Medtronic (MDT) | Ireland | $129.919B | 18.00 |
| Medline (MDLN) | United States | $60.378B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.195B | 0.00 |
| Agilent Technologies (A) | United States | $39.301B | 24.84 |
| GE HealthCare Technologies (GEHC) | United States | $37.303B | 17.84 |
| ResMed (RMD) | United States | $37.266B | 25.79 |
| Koninklijke Philips (PHG) | Netherlands | $28.637B | 18.70 |
| Terumo (TRUMY) | Japan | $20.358B | 22.92 |
| Insulet (PODD) | United States | $19.697B | 61.13 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.349B | 10.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.055B | 0.00 |
| Baxter (BAX) | United States | $10.317B | 8.33 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.233B | 29.60 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.455B | 13.57 |
| BillionToOne (BLLN) | United States | $4.145B | 0.00 |
| Envista Holdings (NVST) | United States | $4.014B | 23.03 |
| ICU Medical (ICUI) | United States | $3.914B | 24.85 |
| Haemonetics (HAE) | United States | $3.278B | 14.59 |
| Prestige Consumer Healthcare (PBH) | United States | $3.257B | 14.85 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| Neogen (NEOG) | United States | $2.159B | 47.26 |
| QuidelOrtho (QDEL) | United States | $2.076B | 13.35 |
| Perrigo (PRGO) | Ireland | $2.075B | 5.20 |
| AtriCure (ATRC) | United States | $1.990B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.945B | 39.15 |
| Curaleaf Holdings (CURLF) | Canada | $1.764B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.687B | 16.85 |
| Green Thumb Industries (GTBIF) | United States | $1.649B | 72.27 |
| Kestra Medical Technologies (KMTS) | United States | $1.442B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.422B | 20.59 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.390B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.251B | 371.14 |
| Capricor Therapeutics (CAPR) | United States | $1.105B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.064B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.979B | 0.00 |
| InMode (INMD) | Israel | $0.890B | 10.06 |
| Valneva SE (VALN) | France | $0.886B | 0.00 |
| Omeros (OMER) | United States | $0.861B | 0.00 |
| CeriBell (CBLL) | United States | $0.842B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.602B | 16.32 |
| Verano Holdings (VRNO) | United States | $0.516B | 0.00 |
| Cerus (CERS) | United States | $0.503B | 0.00 |
| Brainsway (BWAY) | Israel | $0.474B | 80.63 |
| Canopy Growth (CGC) | Canada | $0.431B | 0.00 |
| SNDL (SNDL) | Canada | $0.428B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.426B | 0.00 |
| Quanterix (QTRX) | United States | $0.337B | 0.00 |
| Evolus (EOLS) | United States | $0.329B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.282B | 22.51 |
| TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.245B | 144.33 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| High Tide (HITI) | Canada | $0.230B | 0.00 |
| Organigram Global (OGI) | Canada | $0.219B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Utah Medical Products (UTMD) | United States | $0.199B | 17.54 |
| Sanara MedTech (SMTI) | United States | $0.198B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.195B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.183B | 0.00 |
| Accendra Health (ACH) | United States | $0.163B | 1.64 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 0.00 |
| Apyx Medical (APYX) | United States | $0.151B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.132B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.77 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Exagen (XGN) | United States | $0.111B | 0.00 |
| Biote (BTMD) | United States | $0.104B | 4.56 |
| Sharps Technology (STSS) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 25.23 |
| Nephros (NEPH) | United States | $0.050B | 35.85 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Veru (VERU) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Bonk (BNKK) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.27 |
| Jin Medical (ZJYL) | China | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |